BioPharma Credit PLC Overview
Latest PEG ratio for BioPharma Credit PLC: -32.94 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-32.94
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
BioPharma Credit PLC's peg ratio stands at -32.94. That is below the sector sector average of 10.05. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
BioPharma Credit PLC sits lower the its sector benchmark (10.05) with a PEG ratio of -32.94. That is roughly 427.6% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether -32.94 is attractive depends on BioPharma Credit PLC's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how BioPharma Credit PLC's PEG ratio evolved across reporting periods, while the comparison chart places BPCR.L next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
